Skip to content
Syntara
A clinical‐stage drug development company primarily focused on blood related cancers.
Welcome
People
Board
Management
Pipeline
Clinical Trials
Investors
Investors home page
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Media
Conference Posters
Analyst Reports
Shareholders
Shareholder Services
Corporate Governance
Contact
Welcome
People
Board
Management
Pipeline
Clinical Trials
Investors
Investors home page
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Media
Conference Posters
Analyst Reports
Shareholders
Shareholder Services
Corporate Governance
Contact
Annual & Half-Yearly Reports
You are here:
Home
Investors
Annual & Half-Yearly Reports
Back to Investors home
ASX Announcements
Quarterly Reports
Annual & Half-Yearly Reports
Investor Presentations
Media
Analyst Reports
Subscribe to email alerts
SUBSCRIBE
Go to Top
